Publications by authors named "Pierre Zachee"

37Publications

Acute primary abdominal compartment syndrome due to Clostridium difficile induced toxic megacolon: a case report and review of the literature.

Anaesthesiol Intensive Ther 2019 ;51(4):273-282

Department of Intensive Care, University Hospital of Brussels (UZB), Jette, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/ait.2019.89189DOI Listing
August 2020

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

N Engl J Med 2018 09;379(10):934-947

From Université Lille, Centre Hospitalier Universitaire (CHU), Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille (F.M.), CHU Régional de Nancy, Service d'Hématologie, Vandoeuvre lès Nancy (P.F.), Institut Paoli-Calmettes (R.B.) and Department of Pathology, Institut Paoli-Calmettes, Centre de Recherche en Cancerologie de Marseille, INSERM, Centre National de la Recherche Scientifique, Aix-Marseille Université (L.X.), Marseille, Centre Henri Becquerel, Unité 1245 and Département d'Hématologie, Université de Rouen, Rouen (H.T.), Institut d'Hématologie de Basse Normandie, Caen (C.F.), CHU Le Bocage Service d'Hématologie Clinique, Dijon (R.-O.C.), Hôpital Henri Mondor Unité Hémopathies Lymphoïdes, Créteil (C.H.), Centre Hospitalier Départemental Vendée Service d'Onco-Hématologie, La Roche sur Yon (H.M.), Institut Universitaire du Cancer de Toulouse Oncopole Service d'Hématologie, Toulouse (L.Y.), CHU Bordeaux, Service d'Hématologie, Bordeaux (K.B.), Hôpital Saint Louis Service d'Onco-Hématologie, Paris (P.B.), Gustave Roussy Cancer, Villejuif (V.R.), Centre Hospitalier Annecy Genevois Service, Annecy (N.D.), CHU de Nantes-Hôtel Dieu Service d'Hématologie Clinique, Centre de Recherche en Cancerologie et Immunologie, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Nantes (S.L.G.), Centre Hospitalier Métropole Savoie Service Hématologie, Chambery (G.M.P.), Department of Hematology, CHU Montpellier, University of Montpellier, Montpellier (G.C.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Benite (G.A.S.) - all in France; the Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (N.H.F.); the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.L.P.); the Department of Medicine, Division of Medical Oncology, University of Washington, Seattle (E.N.L.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.W.F.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (N.L.B.); the Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca (A.M.G.-S.), and the Department of Hematology, Hospital Clinic de Barcelona, Barcelona (A.L.-G.) - both in Spain; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec (J.-F.L.), and British Columbia Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver (L.H.S.) - both in Canada; the Department of Hematology and Oncology, Tokai University Hospital, Kanagawa, Japan (K.A.); Instituto Português de Oncologia Lisboa Francisco Gentil Departamento de Hematologia, Lisbon (M.G.S.); the Department of Hematology, CHU Université Catholique de Louvain Namur, Yvoir (M.A.), and the Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp (P.Z.) - both in Belgium; the Department of Hematology, National Cancer Center Hospital, Tokyo, Japan (K.T.); and Celgene, Summit, NJ (D.L., J.W.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805104
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805104DOI Listing
September 2018

Recommendations on the use of ruxolitinib for the treatment of myelofibrosis.

Hematology 2018 May 12;23(4):194-200. Epub 2017 Oct 12.

e Department of Hemato-Oncolocy , Erasme Hospital , Brussels , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10245332.2017.1385192DOI Listing
May 2018

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

J Clin Oncol 2017 Jun 29;35(17):1905-1912. Epub 2017 Mar 29.

Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andrés J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia; Umberto Vitolo, University-Hospital Città della Salute e della Scienza, Turin; Maurizio Martelli, Sapienza University; Stefan Hohaus, Catholic University of the Sacred Heart, Rome; Graziella Pinotti, Fondazione Macchi Hospital, Varese; Caterina Stelitano, Bianchi-Melacrino-Morelli Hospitals, Reggio Calabria; Monica Bellei, University of Modena and Reggio Emilia, Modena, Italy; Reda Bouabdallah, Institut Paoli-Calmettes, Marseille; Gilles Salles, Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Pierre-Benite; Catherine Sebban, Centre Léon Bérard, Lyon; Franck Morschhauser, Claude Huriez Hospital, Lille; Anne Moreau, University Hospital of Nantes, Nantes; Hervé Tilly, Centre Henri Becquerel, Rouen; Corinne Haioun, Henri-Mondor Hospital, Paris Créteil; Corinne Haioun, UPEC, Assistance Publique-Hopitaux de Paris; Catherine Thieblemont, Assistance Publique-Hopitaux de Paris, Hôpital-Saint-Louis, Hematooncology-Université Paris Diderot, Sorbonne Paris-Cité, Paris, France; Ruth Pettengell, St George's University of London, London; Andrew Jack, St James's University Hospital, Leeds; Peter Johnson, Southampton General Hospital, Southampton, United Kingdom; Armando Lopez Guillermo and Elias Campo, Hospital Clinic, Barcelona, Spain; Pierre Zachée, ZNA Stuivenberg, Antwerp; and André Bosly, Mont-Godinne UCL, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6994DOI Listing
June 2017

Reply to M. Lambertini et al.

J Clin Oncol 2017 03 28;35(7):805-806. Epub 2016 Nov 28.

Isabelle Demeestere, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Pauline Brice, St Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Fedro A. Peccatori, European Institute of Oncology, Milan, Italy; Alain Kentos, Jolimont Hospital, Haine-Saint-Paul, Belgium; Jehan Dupuis, Henri Mondor Hospital, Paris, France; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon, Dijon, France; Eric Van Den Neste, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Brussels, Belgium; Julie Dechene, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Viviane De Maertelaer, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Belgium; Dominique Bron, J. Bordet Institute, Brussels, Belgium; and Yvon Englert, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, and Erasme Hospital, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6093DOI Listing
March 2017

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

J Clin Oncol 2016 08 13;34(22):2575-82. Epub 2016 Jun 13.

Clémentine Sarkozy and Gilles Salles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie, Pierre Bénite and Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux Pierre Bénite; Luc Xerri, Aix-Marseille University and Institut Paoli-Calmettes, Marseille; Pierre Feugier, Centre Hospitalier Universitaire de Nancy and INSERM 954 Université de Lorraine, Nancy; Pauline Brice, Hôpital Saint Louis APHP and Université Paris VII; Danielle Canioni, Assistance Publique Hôpitaux de Paris (APHP) Hôpital Universitaire Necker-Enfants Malades; Richard Delarue, APHP Hôpital Universitaire Necker-Enfants Malades and Descartes-Sorbonne Paris Cité University, Paris; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux, Bordeaux; Christiane Mounier, Institut de Cancérologie Lucien Neuwirth, Saint Priest; Jehan Dupuis, Henri Mondor University Hospital, Créteil; Hervé Tilly, Université de Rouen, Rouen, France; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Nick Wickham, University of Adelaide, Adelaide; Marlton Paula, Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane; John Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia; Sirpa Leppa, Helsinki University Hospital Cancer Center and University of Helsinki, Helsinki, Finland; Maria Gomes Da Silva, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal; Fritz Offner, Gent University, Gent; Pierre Zachee, ZNA Stuivenberg, Antwerp, Belgium; and Dolores Caballero, Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7163DOI Listing
August 2016

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

J Clin Oncol 2016 08 23;34(22):2568-74. Epub 2016 May 23.

Isabelle Demeestere, Julie Dechene, Yvon Englert, and Viviane De Maertelaer, Université Libre de Bruxelles; Alain Kentos and Yvon Englert, Erasme Hospital; Eric Van Den Neste, Cliniques Universitaires UCL Saint-Luc; Dominique Bron, J. Bordet Institute, Brussels; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerpen, Belgium; Pauline Brice, St Louis Hospital, APHP; Jehan Dupuis, Hôpital Henri Mondor, Paris; Olivier Casasnovas, CHU de Dijon, Dijon, France; and Fedro A. Peccatori, Istituto Europeo di Oncologia, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.8864DOI Listing
August 2016

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

N Engl J Med 2015 Jan;372(5):426-35

From Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence (A.M.V.), Ospedale di Circolo e Fondazione Macchi, Varese (F. Passamonti), and University of Naples Federico II, Naples (F. Pane) - all in Italy; Hôpital Saint-Louis et Université Paris Diderot, Paris (J.J.K.); Johannes Wesling Clinic, Minden, Germany (M.G.); St. István and St. László Hospital and Semmelweis University, Budapest, Hungary (T.M.); Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia (S.D.); Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.); Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium (P.Z.); Mayo Clinic Cancer Center, Scottsdale, AZ (R.M.); Incyte, Wilmington, DE (S.H., M.M.J., W.G.); Novartis Pharmaceuticals, East Hanover, NJ (J.L., D.H.); Novartis Pharma, Basel, Switzerland (U.P.); and University of Texas M.D. Anderson Cancer Center, Houston (S.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1409002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358820PMC
January 2015

Massilia timonae infection presenting as generalized lymphadenopathy in a man returning to Belgium from Nigeria.

J Clin Microbiol 2011 Jul 27;49(7):2763-5. Epub 2011 Apr 27.

Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.00160-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147811PMC
July 2011

Atypical myeloproliferative disorders in adults.

Authors:
Pierre Zachée

Transfus Apher Sci 2011 Apr;44(2):211-21

ZNA Stuivenberg Department of hematology, Lange Beeldekenstraat, 267 2060 Antwerpen, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2011.01.017DOI Listing
April 2011

Acute myeloid leukemia with bone marrow necrosis and Charcot Leyden crystals.

Am J Hematol 2007 Nov;82(11):1029

Department of Laboratory Medicine, University Hospital Gasthuisberg, Catholic University of Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.20907
Publisher Site
http://dx.doi.org/10.1002/ajh.20907DOI Listing
November 2007

Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements.

Ann Hematol 2005 Feb 10;84(2):89-94. Epub 2004 Sep 10.

Department of Internal Medicine, Ziekenhuisnetwerk Antwerpen Campus Stuivenberg, Lange Beeldekensstraat 267, 2060, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-004-0946-8
Publisher Site
http://dx.doi.org/10.1007/s00277-004-0946-8DOI Listing
February 2005

Plasma exchange-associated immunoglobulin m-negative hantavirus disease after a camping holiday in southern france.

Clin Infect Dis 2004 May 26;38(10):1350-6. Epub 2004 Apr 26.

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, BE-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/383311DOI Listing
May 2004

A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.

Ann Hematol 2004 Jul 18;83(7):455-9. Epub 2004 Mar 18.

Hematology Unit, University Hospital Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-003-0828-5DOI Listing
July 2004